The relationship between agonist intrinsic activity and the rate of endocytosis of muscarinic receptors in a human neuroblastoma cell line

Molecular Pharmacology

Volumn 53, Issue 4, 1998, Pages 759-765

  Szekeres, Philip G ^a   Koenig, Jennifer A ^a   Edwardson, J Michael ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR;

ARTICLE; CELL COMPARTMENTALIZATION; CELL STIMULATION; CELL SURFACE; DRUG RECEPTOR BINDING; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; INTRINSIC SYMPATHOMIMETIC ACTIVITY; LIGAND BINDING; MATHEMATICAL MODEL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SECOND MESSENGER;

EID: 0031969377     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.53.4.759     Document Type: Article

References (28)

1. 2-adrenergic receptor. Biochemistry 34: 15407-15414.
2. Benya RV, Akeson M, Mrozinski J, Jensen RT, and Battey JF (1994) Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and independent processes. Mol Pharmacol 46:495-501.
3. Bogatkewitsch GS, Lenz W, Jakobs KH, and Van Koppen CJ (1996) Receptor internalization delays m4 muscarinic acetylcholine receptor resensitization at the plasma membrane. Mol Pharmacol 50:424-429.
4. Cheung AH, Dixon RAF, Hill WS, Sigal IS, and Strader CD (1990) Separation of the structural requirements for agonist-promoted activation and sequestration of the β-adrenergic receptor. Mol Pharmacol 37:775-779.
5. - lymphoma cells. J Cyclic Nucleotide Protein Phosphorylation Res 10:97-119.
6. Communi D, Vanweyenberg V, and Erneux C (1997) D-myo-Inositol 1,4,5-trisphosphate 3-kinase A is activated by receptor activation through a calcium: calmodulin-dependent protein kinase II phosphorylation mechanism. EMBO J 16:1943-1952.
7. 4 receptor. Biochem J 305:139-143.
8. Hulme EC, Birdsall NJM, and Buckley NJ (1990) Muscarinic receptor subtypes. Annu Rev Pharmacol Toxicol 30:633-673.
9. Hunyady L, Baukal AJ, Balla T, and Catt KJ (1994) Independence of type I angiotensin II receptor endocytosis from G protein coupling and signal transduction. J Biol Chem 269:24798-24804.
10. Keith DE, Murray SR, Zaki PA, Chu PC, Lissin DV, Rang L, Evans CJ, and von Zastrow M (1996) Morphine activates opioid receptors without causing their rapid internalization. J Biol Chem 271:19021-19024.
11. Koenig JA and Edwardson JM (1994) Kinetic analysis of the trafficking of muscarinic acetylcholine receptors between the plasma membrane and intracellular compartments. J Biol Chem 269:17174-17182.
12. Koenig JA and Edwardson JM (1996) Intracellular trafficking of the muscarinic acetylcholine receptor: importance of subtype and cell type. Mol Pharmacol 49: 351-359.
13. Koenig JA and Edwardson JM (1997) Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol Sci 18:276-287.
14. Kong H, Raynor K, Yasuda K, Moe ST, Portoghese PS, Bell GI, and Reisine T (1993) A single residue, aspartic acid 95, in the δ opioid receptor specifies selective high affinity agonist binding. J Biol Chem 268:23055-23058.
15. Mayor S, Presley JF, and Maxfield FR (1993) Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process. J Cell Biol 121:1257-1269.
16. Moro O, Lameh J, and Sadée W (1993) Serine-and threonine-rich domain regulates internalization of muscarinic cholinergic receptors. J Biol Chem 268:6862-6865.
17. 2-adrenergic receptor during agonist-induced steady state redistribution. Mol Pharmacol 50:692-699.
18. Petrou C, Chen L, and Tashjian AH Jr (1997) A receptor-G protein coupling-independent step in the internalization of the thyrotropin-releasing hormone receptor. J Biol Chem 272: 2326-2333.
19. 2-adrenergic receptors permit receptor resensitization. Mol Pharmacol 47:666-676.
20. Roettger BF, Ghanekar D, Rao R, Toledo J, Yingling J, Pinon D, and Miller LJ (1997) Antagonist-stimulated internalization of the G protein-coupled cholecystokinin receptor. Mol Pharmacol 51:357-362.
21. Slowiejko DM, Levey AI, and Fisher SK (1994) Sequestration of muscarinic cholinergic receptors in permeabilized neuroblastoma cells. J Neurochem 62:1795-1803.
22. Sternini C, Spann M, Anton B, Keith DE, Bunnett NW, von Zastrow M, Evans C, and Brecha NC (1996) Agonist-selective endocytosis of μ opioid receptor by neurons in vivo. Proc Natl Acad Sci USA 93:9241-9246.
23. Thompson AK and Fisher SK (1990) Relationship between agonist-induced muscarinic receptor loss and desensitization of stimulated phosphoinositide turnover in two neuroblastomas: methodological considerations. J Pharmacol Exp Ther 252: 744-752.
24. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, and Fisher SK (1991) The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. J Biol Chem 266:23856-23862.
25. Wall SJ, Yasuda RP, Li M, and Wolfe BB (1991) Development of an antiserum against m3 receptors: Distribution of m3 receptors in rat tissues and clonal cell lines; Mol Pharmacol 40:783-789.
26. Wang WW, Shahrestanifar M, Jin J, and Howells RD (1995) Studies on μ and δ opioid receptor selectivity utilizing chimeric and site-mutagenized receptors. Proc Natl Acad Sci USA 92:12436-12440.
27. Wess J, Gdula D, and Brann MR (1991) Site-directed mutagenesis of the m3 muscarinic receptor: Identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. EMBO J 10:3729-3734.
28. 2+ signalling in human neuroblastoma cells. Br J Pharmacol 114:1133-1142.